Trial intelligence / Profile preview

Azacitidine plus lisaftoclax in newly diagnosed higher-risk MDS (Phase II, single-arm)

ChiCTR2600118868Phase 2Not yet recruiting

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Feb 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1